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Background: Heart rate reduction contributes image quality during coronary CT angiography (CCTA). It is also effective for radiation dose reduction. 
The purpose of this prospective multicenter study was to assess the effectiveness of the new short-acting intravenous ρ1-receptor blocker, landiolol 
hydrochloride, in reducing the radiation dose to patients undergoing CCTA with the latest scanners.
Methods: Two hundred nineteen patients with suspected ischemic heart disease and heart rates of 50-80 beats/min underwent CCTA about 4-7 
min after administration of landiolol hydrochloride. We measured the heart rates immediately before the start of landiolol hydrochloride injection 
and during the CCTA scan, and compared the actual effective dose with the estimated (virtual) effective dose calculated based on the heart rate 
before the administration of landiolol on the CT console. A paired t-test was used for the analyses.
results: The heart rate during the CCTA (59.9 ± 6.4 beats/min) was significantly lower than that immediately before the landiolol hydrochloride 
injection (69.3 ± 7.3 beats/min) (P < 0.001), and use of the dose reduction protocol, e.g., prospective triggering, was possible in 188 patients 
(85.8%). The theoretical mean percent dose reduction with the use of landiolol hydrochloride was 50% (9.0 vs. 4.5 mSv) (P < 0.001).
conclusions: Use of landiolol hydrochloride allows the radiation dose during CCTA to be reduced by approximately 50%.
